vs
Enovis CORP（ENOV）与盖茨工业（GTES）财务数据对比。点击上方公司名可切换其他公司
盖茨工业的季度营收约是Enovis CORP的1.6倍（$856.2M vs $548.9M），盖茨工业净利率更高（6.0% vs -104.1%，领先110.0%），盖茨工业同比增速更快（3.2% vs -2.2%），盖茨工业自由现金流更多（$251.0M vs $29.1M），过去两年Enovis CORP的营收复合增速更高（9.8% vs -0.4%）
Enovis是一家专注于骨科领域的医疗科技企业，其前身是1995年由米切尔·雷尔斯和史蒂文·雷尔斯兄弟创立的科尔法克斯公司。公司总部位于特拉华州威尔明顿，目前在全球12个地点开展业务，拥有超过5000名员工，于纽约证券交易所上市，股票代码为ENOV。
盖茨工业总部位于美国科罗拉多州丹佛市，是动力传动带及流体动力产品的专业制造商，产品广泛应用于各类工业和汽车领域。公司员工规模超1.5万人，在美洲、欧洲、亚洲、澳洲及中东均设有销售和生产基地。
ENOV vs GTES — 直观对比
营收规模更大
GTES
是对方的1.6倍
$548.9M
营收增速更快
GTES
高出5.4%
-2.2%
净利率更高
GTES
高出110.0%
-104.1%
自由现金流更多
GTES
多$221.9M
$29.1M
两年增速更快
ENOV
近两年复合增速
-0.4%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $548.9M | $856.2M |
| 净利润 | $-571.1M | $51.3M |
| 毛利率 | 59.9% | 38.0% |
| 营业利润率 | -101.7% | 12.8% |
| 净利率 | -104.1% | 6.0% |
| 营收同比 | -2.2% | 3.2% |
| 净利润同比 | 18.8% | 40.2% |
| 每股收益（稀释后） | $-9.99 | $0.19 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ENOVGTES
| Q4 25 | $548.9M | $856.2M | ||
| Q3 25 | $564.5M | $855.7M | ||
| Q2 25 | $558.8M | $883.7M | ||
| Q1 25 | — | $847.6M | ||
| Q4 24 | $561.0M | $829.4M | ||
| Q3 24 | $505.2M | $830.7M | ||
| Q2 24 | $525.2M | $885.5M | ||
| Q1 24 | $516.3M | $862.6M |
净利润ENOVGTES
| Q4 25 | $-571.1M | $51.3M | ||
| Q3 25 | $-36.7M | $81.6M | ||
| Q2 25 | $-56.0M | $56.5M | ||
| Q1 25 | — | $62.0M | ||
| Q4 24 | $-703.2M | $36.6M | ||
| Q3 24 | $-31.5M | $47.6M | ||
| Q2 24 | $-18.6M | $70.7M | ||
| Q1 24 | $-72.0M | $40.0M |
毛利率ENOVGTES
| Q4 25 | 59.9% | 38.0% | ||
| Q3 25 | 59.3% | 39.9% | ||
| Q2 25 | 59.5% | 40.8% | ||
| Q1 25 | — | 40.7% | ||
| Q4 24 | 54.8% | 40.4% | ||
| Q3 24 | 56.7% | 40.4% | ||
| Q2 24 | 55.0% | 40.4% | ||
| Q1 24 | 57.7% | 38.3% |
营业利润率ENOVGTES
| Q4 25 | -101.7% | 12.8% | ||
| Q3 25 | -3.0% | 13.5% | ||
| Q2 25 | -8.4% | 13.1% | ||
| Q1 25 | — | 14.7% | ||
| Q4 24 | -118.5% | 13.6% | ||
| Q3 24 | -6.3% | 13.6% | ||
| Q2 24 | -8.4% | 15.4% | ||
| Q1 24 | -6.8% | 13.5% |
净利率ENOVGTES
| Q4 25 | -104.1% | 6.0% | ||
| Q3 25 | -6.5% | 9.5% | ||
| Q2 25 | -10.0% | 6.4% | ||
| Q1 25 | — | 7.3% | ||
| Q4 24 | -125.4% | 4.4% | ||
| Q3 24 | -6.2% | 5.7% | ||
| Q2 24 | -3.5% | 8.0% | ||
| Q1 24 | -13.9% | 4.6% |
每股收益（稀释后）ENOVGTES
| Q4 25 | $-9.99 | $0.19 | ||
| Q3 25 | $-0.64 | $0.31 | ||
| Q2 25 | $-0.98 | $0.22 | ||
| Q1 25 | — | $0.24 | ||
| Q4 24 | $-12.69 | $0.15 | ||
| Q3 24 | $-0.58 | $0.18 | ||
| Q2 24 | $-0.34 | $0.26 | ||
| Q1 24 | $-1.32 | $0.15 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $33.6M | $812.1M |
| 总债务越低越好 | $1.4B | $2.2B |
| 股东权益账面价值 | $2.0B | $3.3B |
| 总资产 | $4.4B | $7.2B |
| 负债/权益比越低杠杆越低 | 0.67× | 0.67× |
8季度趋势，按日历期对齐
现金及短期投资ENOVGTES
| Q4 25 | $33.6M | $812.1M | ||
| Q3 25 | $44.1M | $689.4M | ||
| Q2 25 | $38.5M | $719.7M | ||
| Q1 25 | — | $640.2M | ||
| Q4 24 | $48.2M | $682.0M | ||
| Q3 24 | $35.4M | $574.4M | ||
| Q2 24 | $35.0M | $579.7M | ||
| Q1 24 | $66.3M | $522.2M |
总债务ENOVGTES
| Q4 25 | $1.4B | $2.2B | ||
| Q3 25 | $1.4B | $2.2B | ||
| Q2 25 | $1.4B | $2.3B | ||
| Q1 25 | — | $2.3B | ||
| Q4 24 | $1.3B | $2.4B | ||
| Q3 24 | $1.3B | $2.4B | ||
| Q2 24 | $1.3B | $2.3B | ||
| Q1 24 | $1.3B | $2.3B |
股东权益ENOVGTES
| Q4 25 | $2.0B | $3.3B | ||
| Q3 25 | $2.6B | $3.4B | ||
| Q2 25 | $2.6B | $3.3B | ||
| Q1 25 | — | $3.1B | ||
| Q4 24 | $2.6B | $3.0B | ||
| Q3 24 | $3.3B | $3.1B | ||
| Q2 24 | $3.3B | $3.2B | ||
| Q1 24 | $3.3B | $3.2B |
总资产ENOVGTES
| Q4 25 | $4.4B | $7.2B | ||
| Q3 25 | $5.0B | $7.1B | ||
| Q2 25 | $4.9B | $7.2B | ||
| Q1 25 | — | $6.9B | ||
| Q4 24 | $4.7B | $6.8B | ||
| Q3 24 | $5.6B | $7.1B | ||
| Q2 24 | $5.4B | $7.0B | ||
| Q1 24 | $5.5B | $7.0B |
负债/权益比ENOVGTES
| Q4 25 | 0.67× | 0.67× | ||
| Q3 25 | 0.54× | 0.66× | ||
| Q2 25 | 0.53× | 0.72× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | 0.52× | 0.78× | ||
| Q3 24 | 0.40× | 0.76× | ||
| Q2 24 | 0.41× | 0.73× | ||
| Q1 24 | 0.40× | 0.74× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $82.6M | $269.8M |
| 自由现金流经营现金流 - 资本支出 | $29.1M | $251.0M |
| 自由现金流率自由现金流/营收 | 5.3% | 29.3% |
| 资本支出强度资本支出/营收 | 9.7% | 2.2% |
| 现金转化率经营现金流/净利润 | — | 5.26× |
| 过去12个月自由现金流最近4个季度 | $22.8M | $404.9M |
8季度趋势，按日历期对齐
经营现金流ENOVGTES
| Q4 25 | $82.6M | $269.8M | ||
| Q3 25 | $47.8M | $98.0M | ||
| Q2 25 | $-1.6M | $103.0M | ||
| Q1 25 | — | $7.3M | ||
| Q4 24 | $88.3M | $190.9M | ||
| Q3 24 | $53.6M | $115.9M | ||
| Q2 24 | $7.8M | $93.8M | ||
| Q1 24 | $-36.2M | $-21.0M |
自由现金流ENOVGTES
| Q4 25 | $29.1M | $251.0M | ||
| Q3 25 | $3.4M | $80.5M | ||
| Q2 25 | $-44.9M | $83.6M | ||
| Q1 25 | — | $-10.2M | ||
| Q4 24 | $35.1M | $167.6M | ||
| Q3 24 | $2.4M | $94.0M | ||
| Q2 24 | $-31.6M | $71.9M | ||
| Q1 24 | $-73.1M | $-37.0M |
自由现金流率ENOVGTES
| Q4 25 | 5.3% | 29.3% | ||
| Q3 25 | 0.6% | 9.4% | ||
| Q2 25 | -8.0% | 9.5% | ||
| Q1 25 | — | -1.2% | ||
| Q4 24 | 6.3% | 20.2% | ||
| Q3 24 | 0.5% | 11.3% | ||
| Q2 24 | -6.0% | 8.1% | ||
| Q1 24 | -14.2% | -4.3% |
资本支出强度ENOVGTES
| Q4 25 | 9.7% | 2.2% | ||
| Q3 25 | 7.9% | 2.0% | ||
| Q2 25 | 7.7% | 2.2% | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | 9.5% | 2.8% | ||
| Q3 24 | 10.1% | 2.6% | ||
| Q2 24 | 7.5% | 2.5% | ||
| Q1 24 | 7.2% | 1.9% |
现金转化率ENOVGTES
| Q4 25 | — | 5.26× | ||
| Q3 25 | — | 1.20× | ||
| Q2 25 | — | 1.82× | ||
| Q1 25 | — | 0.12× | ||
| Q4 24 | — | 5.22× | ||
| Q3 24 | — | 2.43× | ||
| Q2 24 | — | 1.33× | ||
| Q1 24 | — | -0.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ENOV
| Reconstructive Segment | $258.0M | 47% |
| Surgical | $129.0M | 23% |
| Prevention And Recovery | $92.6M | 17% |
| Other Prevention And Recovery | $71.4M | 13% |
GTES
| Power Transmission Segment | $536.5M | 63% |
| Fluid Power Segment | $319.7M | 37% |
